ArticleAnnals of hematology2025

Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy.

Jinya Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.